Abstract
Differential localization of the type II cAMP-dependent protein kinase (PKA) is achieved by interaction of the regulatory subunit (RII) with A-kinase anchor proteins (AKAPs). Anchoring is a likely means to adapt PKA for regulation of cAMP-responsive events through colocalization of the kinase with preferred substrates. Using an interaction cloning strategy with an RII alpha protein probe, we have identified a 655-amino acid protein (named AKAP100). Recombinant AKAP100, expressed in Escherichia coli, binds RII alpha in a solid-phase overlay assay. The cellular and subcellular distribution of AKAP100 was analyzed by various methods. Northern blot analysis with the AKAP100 cDNA as a probe detected an 8-kilobase message in some human tissues including various brain regions; however, the message was predominately expressed in cardiac and skeletal muscle. Anti-AKAP100 antibodies confirmed expression in the rat cardiac and skeletal muscle cell lines, H9c2 and L6P, whereas immunohistochemical analysis revealed that AKAP100 was localized to the sarcoplasmic reticulum of both cell types. RII was also detected in these regions. AKAP100 was detected in preparations of RII purified from L6P cell extracts by cAMP-agarose affinity chromatography. Collectively, these results suggest that AKAP100 functions to maintain the type II PKA at the sarcoplasmic reticulum.
Highlights
Differential localization of the type II cAMP-dependent protein kinase (PKA) is achieved by interaction of the regulatory subunit (RII) with A-kinase anchor proteins (AKAPs)
Anti-AKAPIOO antibodies confirmed expression in the rat cardiac and skeletal muscle cell lines, H9c2 and L6P, whereas immunohistochemical analysis revealed that AKAPIOO was localized to the sarcoplasmic reticulum of both cell types
AKAPIOO was detected in preparations of RII purified from L6P cell extracts by cAMP-agarose affinity chromatography
Summary
Vol 270, No 16, Issue of April 21, pp. 9327-9333, 1995 Printed in U.S.A. (Received for publication, November 18, 1994, and in revised form, January 31, 1995). AKAPIOO was detected in preparations of RII purified from L6P cell extracts by cAMP-agarose affinity chromatography These results suggest that AKAPIOO functions to maintain the type II PKA at the sarcoplasmic reticulum. Synthetic peptides patterned after the amphipathic helix bind RII and the type II PKA holoenzyme with nanomolar affinity and can block interaction with AKAPs [24]. Biochemical and immunological studies have confirmed that both PKA and calcineurin are targeted to subcellular sites by association with AKAP79, possibly to regulate the phosphorylation state of key neuronal substrates [28]. Biochemical and immunochemical analyses suggest that AKAP100 and RII associate in vivo at the sarcoplasmic reticulum
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.